Wikidata

(Q40702351)

English

A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity

scientific article published on April 1994

In more languages

Statements

title
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
8142644
retrieved
22 September 2017
author name string
Caron PC
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
8142644
retrieved
22 September 2017
Jurcic JG
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
8142644
retrieved
22 September 2017
Scott AM
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
8142644
retrieved
22 September 2017
Finn RD
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
8142644
retrieved
22 September 2017
Divgi CR
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
8142644
retrieved
22 September 2017
Graham MC
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
8142644
retrieved
22 September 2017
Jureidini IM
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
8142644
retrieved
22 September 2017
Sgouros G
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
8142644
retrieved
22 September 2017
Tyson D
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
8142644
retrieved
22 September 2017
publication date
1 April 1994
1 reference
stated in
Europe PubMed Central
PubMed ID
8142644
retrieved
22 September 2017
page(s)
1760-1768
1 reference
stated in
Europe PubMed Central
PubMed ID
8142644
retrieved
22 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40702351&oldid=1904946441"